downside of glp 1 drugs GLP-1 medication side effects for diabetes and weight loss The GLP-1 Agonists and Obesity:

In schizophrenia, immune activation upregulates pro-inflammatory cytokines (e.g., IFN-, IL-1, TNF-), which activate indoleamine 2,3-dioxygenase (IDO) via both IFN- receptor (IFN-R)-dependent and independent pathways (e.g., synergistic action of TLR4, IL-1R, TNF-R) (215)

The most common injectable dose for research purposes appears to be 1-2 mg per day over a thirty-day treatment course

H., & Ingram, J

The evidence is overwhelming that nearly everyone can benet from becoming more physically active

(See PRECAUTIONS.) Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit (see HOW SUPPLIED)